BIODEXA PHARMACEUTICALS PLC

Watch

Share

BDRX·59564R708·US·ADR·Healthcare - Biotechnology

BDRX (BIODEXA PHARMACEUTICALS PLC) is held by 1 institutional investors as of Q2 2026. Largest holders: RHUMBLINE ADVISERS ($8). Net institutional sentiment: Bearish.

1

Holders

$8

Total Value

0% (2)

Consensus

0 buying - 2 selling

13F: Jun 30, 2026Insider & Congress: Updated regularly

Smart Money Verdict

View all

Loading verdict

Institutional (13F)61

Insider (Form 4)81

Activist (13D/13G)79

Congressional (STOCK Act)70

Holder Quality

17

★★★★★

Elite

77

★★★★

Strong

25

★★★

Solid

63

★★

Below

62

★

Weak

Held by 1 fund

Who's Trading

Source dates: Price Oct 12, 2026 · Insiders none · Activists none · Congress none

No recent insider, activist, or congressional trades for BDRX.

Top Holders

Top Holders (1)History

AllNewIncreasedHeldDecreasedExitedFirst report

Checking access…

Fund	Action	Shares	Value	Weight	Est. P&L	Conviction
UBS Group AG	Exited	0(-100.0%)	$78	0.0%	-56.50%	0
RHUMBLINE ADVISERS	Decreased	3(-84.2%)	$8	0.0%	-85.69%	0

BDRXBIODEXA PHARMACEUTICALS PLC

1M3M6M1Y3Y5Y

Continue exploring

Smart money flow

Track where institutional capital is flowing

Discover new institutional entries

Fresh positions initiated this quarter

Check sector trends

Capital flows across GICS sectors

Other Healthcare stocks held by institutions

UNHUNITEDHEALTH GROUP INC

417 holders · $300.5B

LLYELI LILLY & CO

416 holders · $881.6B

TMOTHERMO FISHER SCIENTIFIC INC

401 holders · $151.5B

JNJJOHNSON & JOHNSON

398 holders · $415.6B

DHRDANAHER CORP

395 holders · $98.9B

ISRGINTUITIVE SURGICAL INC

394 holders · $111.8B

MRKMERCK & CO. INC.

391 holders · $230.3B

ABBVABBVIE INC

386 holders · $303.9B

BSXBOSTON SCIENTIFIC CORP

386 holders · $52.4B

ABTABBOTT LABORATORIES

383 holders · $114.2B

High Conviction Moves-Smart Money Convergence-Fund Consensus-Double-Down Detection

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer